Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Childhood trauma and psychological outcomes following psychedelic use: a scoping reviewnpj Mental Health Research · 2026-07-30Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping reviewPsychedelics · 2026-07-26A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-09PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-21Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience.Journal of psychopharmacology (Oxford, England) · 2026-05-01A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01Enlightenment in a Pill-Testing the Efficacy of PsilocybinJAMA Psychiatry · 2026-05-01PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.Palliative medicine · 2026-04-01“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practiceDrugs Education Prevention and Policy · 2026-03-22Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.BMJ supportive & palliative care · 2026-02-27The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.Journal of eating disorders · 2026-01-03Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin.The European journal of neuroscience · 2025-12-01Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment.EClinicalMedicine · 2025-12-01Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder.Neuropharmacology · 2025-11-15Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-02Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.UNC Libraries · 2025-10-09A lexicon for psychedelic research and treatmentDrug Science Policy and Law · 2025-08-31Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.Translational psychiatry · 2025-08-29“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-25Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.Psychiatry and clinical psychopharmacology · 2025-07-30Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01Is there mush-room to improve the environmental sustainability of psilocybin production?Journal of CO2 Utilization · 2025-06-10In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assaysDrug Metabolism and Pharmacokinetics · 2025-06-01Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogsJournal of Pharmacological and Toxicological Methods · 2025-05-01Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.BMJ open · 2025-04-15Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin.European journal of pharmacology · 2025-03-15Participants' Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.PsyArXiv · 2025-02-25Psychedelic Information TheoryProceedings of the Annual Conference of CAIS / Actes du congrès annuel de l ACSI · 2025-02-06When death is desired: A case of MAiD & the CL psychiatrist.Palliative & supportive care · 2025-01-21Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Therapeutic advances in psychopharmacology · 2025-01-01Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.General hospital psychiatry · 2025-01-01Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09Psilocybin for clinical indications: A scoping review.Journal of psychopharmacology (Oxford, England) · 2024-10-01B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-12Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocolWellcome Open Res · 2024-07-24Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Pharmacology & therapeutics · 2024-06-01Evidence versus expectancy: the development of psilocybin therapy.BJPsych bulletin · 2024-04-01Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis.Cancer · 2024-04-01UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.BMJ open · 2024-03-14Effect of a single psilocybin treatment on Fos protein expression in male rat brain.Neuroscience · 2024-02-16The development of psilocybin therapy for treatment-resistant depression: an update.BJPsych bulletin · 2024-02-01Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.Neuropsychiatric disease and treatment · 2024-01-01Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action".Frontiers in psychiatry · 2024-01-01Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.Psychiatric research and clinical practice · 2024-01-01Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.Wellcome open research · 2024-01-01Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphereAuthorea Preprints · 2023-11-17Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapyJournal of Psychedelic Studies · 2023-08-21Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.Journal of psychopharmacology (Oxford, England) · 2023-07-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy--dimethyltryptamine in Mice.ACS pharmacology & translational science · 2023-04-14Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.Journal of affective disorders · 2023-04-01Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?Clinical Chemistry · 2023-03-07Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.Fungal genetics and biology: FG & B · 2023-03-01Psilocybin therapy for depression. A good trip?Journal of mental health (Abingdon, England) · 2023-02-01Psychedelic Drug Legislative Reform and Legalization in the US.JAMA psychiatry · 2023-01-01Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.Frontiers in psychiatry · 2023-01-01Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.Neuropsychiatric disease and treatment · 2023-01-01Group psychedelic therapy: empirical estimates of cost-savings and improved access.Frontiers in psychiatry · 2023-01-01Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS pharmacology & translational science · 2022-11-11Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Postpartum depression: A role for psychedelics?Journal of psychopharmacology (Oxford, England) · 2022-08-01Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-29Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.ACS omega · 2022-07-19Increased global integration in the brain after psilocybin therapy for depression.Nature medicine · 2022-04-01Psychedelics hold promise for primary care researchFamily Practice · 2022-01-24Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta crystallographica. Section C, Structural chemistry · 2022-01-01The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01P.0623 The clinical relevance of the pharmacokinetics of psilocybinEuropean Neuropsychopharmacology · 2021-12-01Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.BMJ open · 2021-12-01Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08Psilocybin and MDMA for the treatment of trauma-related psychopathology.International review of psychiatry (Abingdon, England) · 2021-05-01Psilacetin derivatives: fumarate salts of the methyl-ethyl, methyl-allyl and diallyl variants of the psilocin prodrugActa Crystallographica Section E Crystallographic Communications · 2021-02-01Psilocybin: From Serendipity to Credibility?Frontiers in psychiatry · 2021-01-01Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01Psilocybin occasioned mystical-type experiences.Human psychopharmacology · 2020-09-01Oregon's Pioneering Effort to Enact State Law to Allow Access to PsilocybinSSRN Electronic Journal · 2020-08-13Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to PsychedelicsProceedings of the 2020 CHI Conference on Human Factors in Computing Systems · 2020-04-20Emotions and brain function are altered up to one month after a single high dose of psilocybin.Scientific reports · 2020-02-10Medicinal use of psilocybin: Reducing restrictions on research and treatment.Conservative Drug Policy Reform Group · 2020-01-01The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocinActa Crystallographica Section E Crystallographic Communications · 2019-09-01Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrugActa Crystallographica Section E Crystallographic Communications · 2019-06-01T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.Future medicinal chemistry · 2019-02-01Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.Frontiers in psychiatry · 2019-01-01Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.Journal of psychopharmacology (Oxford, England) · 2018-12-01Psychiatry & the psychedelic drugs. Past, present & future.Neuropharmacology · 2018-11-01Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-24Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2018-02-01Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.Frontiers in psychology · 2016-01-01Psilocybin and Obsessive Compulsive Disorder.Journal of psychoactive drugs · 2014-01-01Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia bulletin · 2013-11-01Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.Journal of psychopharmacology (Oxford, England) · 2013-09-01Animal models of serotonergic psychedelics.ACS chemical neuroscience · 2013-01-16Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences of the United States of America · 2012-02-07P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-07Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A ReceptorThe FASEB Journal · 2006-03-01Patterns of recreational drug use at dance events in Edinburgh, Scotland.Addiction (Abingdon, England) · 2001-07-01The problem of psilocybin mushroom abuse.Human toxicology · 1982-10-01Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.Psychopharmacology · 1982-01-01Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat.Pharmacology, biochemistry, and behavior · 1977-04-01Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbitUA Campus Repository (The University of Arizona) · 1976-12-31Comparison of the discriminative stimulus properties of delta9-THC and psilocybin in rats.Pharmacology, biochemistry, and behavior · 1975-01-01Psilocybin-induced contraction of nearby visual space.Agents and actions · 1970-08-01ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF3-SUBSTITUTED INDOLESCanadian Journal of Chemistry · 1963-09-30An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809).The Journal of pharmacology and experimental therapeutics · 1963-04-01AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)The Journal of Pharmacology and Experimental Therapeutics · 1963-03-31Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.The Journal of nervous and mental disease · 1960-11-01